Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

SeaSpine Sees Prelim. Q3 Revenue $66.7M-$67.2M, Up 44-45% YoY

Author: Bill Haddad | October 11, 2022 06:10am

Preliminary and Unaudited Third Quarter 2022 Financial Results

Total revenue is expected to range from $66.7 to $67.2 million, reflecting 44% to 45% year-over-year growth
U.S. revenue is expected to range from $50.9 to $51.2 million, reflecting 23% to 24% year-over-year growth
- U.S. spinal implants and enabling technologies revenue is expected to reflect 29% to 30% year-over-year growth
- U.S. orthobiologics revenue is expected to reflect 17% to 18% year-over-year growth
International revenue is expected to range from $15.8 to $16.0 million, reflecting 203% to 207% year-over-year growth
Cash and cash equivalents at September 30, 2022 totaled $46.8 million, and included $25.8 million of outstanding borrowings against the Company's credit facility

Posted In: SPNE